Potentiation of the central nervous system effects of DOPA by decarboxylase inhibition: possible direct role of this neuroamino acid in brain mechanisms.
D000378:Agonistic Behavior / Q000187:drug effects; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000201:enzymology; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004220:Disulfides / Q000494:pharmacology; D004296:Dopa Decarboxylase / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005071:Evoked Potentials / Q000187:drug effects*; D008750:Methyldopa / Q000494:pharmacology*; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010293:Pargyline / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013003:Somatosensory Cortex / Q000187:drug effects*; D013268:Stimulation, Chemical; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D014793:Visual Cortex / Q000187:drug effects*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004220:Disulfides; D004791:Enzyme Inhibitors; D008781:Methyltyrosines; D010627:Phenethylamines; D010879:Piperazines; D013438:Sulfhydryl Compounds; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010293:Pargyline; D004296:Dopa Decarboxylase